Comparative analysis of rituximab or obinutuzumab combined with CHOP in first-line treatment of follicular lymphoma

PURPOSE: Rituximab (R) or obinutuzumab (G) combined with CHOP chemotherapy are used in previously untreated follicular lymphoma (FL). The aim is to compare in real life setting the efficacy and safety of these therapeutic strategies and assess the economic impact of introducing G. METHODS: This retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Claustre, Gwladys, Boulanger, Coralie, Maloisel, Frédéric, Etienne-Selloum, Nelly, Fornecker, Luc-Matthieu, Durot, Eric, Slimano, Florian, Graff, Véronique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255466/
https://www.ncbi.nlm.nih.gov/pubmed/35789429
http://dx.doi.org/10.1007/s00432-022-04155-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255466/
https://www.ncbi.nlm.nih.gov/pubmed/35789429
http://dx.doi.org/10.1007/s00432-022-04155-2

Ejemplares similares